Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition

Journal of Virology

Volumn 70, Issue 5, 1996, Pages 3298-3301

  Roden, Richard B S ^a   Hubbert, Nancy L ^a   Kirnbauer, Reinhard ^b   Christensen, Neil D ^c   Lowy, Douglas R ^a   Schiller, John T ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY;

ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; CROSS REACTION; HEMAGGLUTINATION INHIBITION; NONHUMAN; PRIORITY JOURNAL; VIRUS ADSORPTION; VIRUS NEUTRALIZATION; WART VIRUS;

EID: 0029990266     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.5.3298-3301.1996     Document Type: Article

References (32)

1. Bosch, F. X., M. M. Manos, N. Muaoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, K. V. Shah, and I. B. S. C. C. Study Group. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide prospective J. Natl Cancer Inst. 87:796-802.
2. Breitburd, F., R. Kirnbauer, N. L. Hubbert, B. Nonnenmacher, C. Trin-Dinh-Desmarquet, G. Orth, J. T. Schiller, and D. R. Lowy. 1995. Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J. Virol. 69:3959-3963.
3. Chan, S. Y., H. Delius, A. L. Halpern, and H. U. Bernard. 1995. Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J. Virol. 69:3074-3083.
4. Cheng, G., J. P. Icenogle, R. Kirnbauer, N. L. Hubbert, M. E. St. Louis, C. Han, E. I. Svare, S. Kruger Kjaer, D. R. Lowy, and J. T. Schiller. 1995. Divergent human papillomavirus type 16 variants are serologically cross-reactive. J Infect. Dis. 172:1584-1587.
5. 4a Christensen, N. D. Unpublished data.
6. Christensen, N. D., R. Hopfl, S. L. DiAngelo, N. M. Cladel, S. D. Patrick, P. A. Welsh, L. R. Budgeon, C. A. Reed, and J. W. Kreider. 1994. Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies. J. Gen. Virol, 75:2271-2276.
7. Christensen, N. D., R. Kirnbauer, J. T. Schiller, S. J. Ghim, R. Schlegel, A. B. Jenson, and J. W. Kreider. 1994. Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes. Virology 205:329-335.
8. Christensen, N. D., and J. W. Kreider. 1990. Antibody-mediated neutralization in vivo of infectious papillomaviruses. J Virol. 64:3151-3156.
9. Christensen, K. D., and J. W. Kreider. 1991. Neutralization of CRPV infectivity by monoclonal antibodies that identify conformational epitopes on intact virions. Virus Res 21:169-179.
10. Christensen, N. D., and J. W. Kreider. 1993. Monoclonal antibody neutralization of BPV-1. Virus Res. 28:195-202
11. Christensen, N. D., J. W. Kreider, N. M. Cladel, S. D. Patrick, and P. A. Welsh. 1990. Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11. J. Virol. 64:5678-5681.
12. Favre, M., F. Breitburd, O. Croissant, and G. Orth, 1974. Hemagglutinating activity of bovine papilloma virus. Virology 60:572-578.
13. Hagensee, M., and D. Galloway. 1993. Growing human papillomaviruses and virus-like particles in the laboratory. Papillomavirus Rep. 4:121-124.
14. Hagensee, M. E., N. Yaegashi, and D. A. Galloway. 1993. Self-assembly of human papillomavirus type 1 capsids by expression of the LI protein alone or by coexpression of the L1 and L2 capsid proteins. J. Virol. 67:315-322.
15. Icenogle, J. P., M. Laga, D. Miller, A. T. Manoka, R. A. Tucker, and W. C. Reeves. 1992. Genotypes and sequence variants of human papillomavirus DNAs from human immunodeficiency virus type 1-infected women with cervical intraepithelial neoplasia. J. Infect. Dis. 166:1210-1216.
16. Jarrett, W. F. H., B. W. O'Neill, J. M. Gaukroger, K. T. Smith, H. M. Laird, and M. S. Campo. 1990. Studies on vaccination against papillomaviruses: the immunity after infection and vaccination with bovine papillomaviruses of different types. Vet. Rec. 126:473-475.
17. Kirnbauer, R., F. Booy, N. Cheng, D. R. Lowy, and J. T. Schiller. 1992. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. USA 89:12180-12184
18. Kirnbauer, R., L. M. Chandrachud, B. W. O'Neil, E. R. Wagner, G. J. Grindlay, A. Armstrong, G. M. McGarvie, J. T. Schiller, D. R. Lowy, and M. S. Campo. Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization. Submitted for publication.
19. Kirnbauer, R., J. Taub, H. Greenstone, R. Roden, M. Dürst, L. Gissmann, D. R. Lowy, and J. T. Schiller. 1993. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J. Virol. 67: 6929-6936.
20. Lowy, D. R., R. Kirnbauer, and J. T. Schiller. 1994. Genital human papillomavirus infection. Proc Natl. Acad. Sci. USA 91:2436-2440.
21. Robbins, J. B., R. Schneerson, and S. C. Szu. 1995. Hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J. Infect. Dis. 171:1387-1398.
22. Roden, R. B. S., N. L. Hubbert, R. Kirnbauer, F. Breitburd, D. R. Lowy, and J. T. Schiller. 1995. Papillomavirus L1 capsids agglutinate mouse erythrocytes through a proteinaceous receptor. J. Virol. 69:5147-5151
23. Roden, R. B. S., R. Kirnbauer, A. B. Jenson, D. R. Lowy, and J. T. Schiller. 1994. Interaction of papillomaviruses with the cell surface. J. Virol. 68: 7260-7266
24. Roden, R. B. S., E. M. Weissinger, D. W. Henderson, F. Booy, R. Kirnbauer, J. F. Mushinski, D. R. Lowy, and J. T. Schiller. 1994. Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins. J Virol. 68:7570-7574.
25. Rose, R. C., W. Bonnez, C. Da Rin, D. J. McCance, and R. C. Reichman. 1994. Serological differentiation of human papillomavirus types 11, 16 and 18 using recombinant virus-like particles. J Gen. Virol. 75:2445-2449.
26. Rose, R. C., W. Bonnez, R. C. Reichman, and R. L. Garcea. 1993 Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles. J. Virol 67:1936-1944.
27. Sasagawa, T., P. Pushko, G. Steers, S. E. Gschmeissner, M. A. Hajibagheri, J. Finch, L. Crawford, and M. Tommasino. 1995. Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe. Virology 206:126-135.
28. Schiller, J. T., and M. Okun. 1996. Papillomavirus vaccines: current status and future prospects. Adv Dermatol. 11:355-380.
29. Seedorf, K., G. Krummer, M. Durst, S. Suhai, and W. G. Rowekamp. 1985. Human papillomavirus type 16 DNA sequence. Virology 145:181-185.
30. Suzich, J. A., S. Ghim, F. J. Palmer-Hill, W. I. White, J. K. Tamura, J. Bell, J. A. Newsome, A. B. Jenson, and R. Schlegel. 1995. Systemic immunization with papillomavirus Li protein completely prevents the development of viral mucosal papillomas. Proc. Natl. Acad. Sci. USA 92:11553-11557
31. van Belkum, A., L. Juffermans, L. Schrauwen, G. van Doornum, M. Burger, and W. Quint. 1995. Genotyping human papillomavirus type 16 isolates from persistently infected promiscuous individuals and cervical cancer patients. J. Clin. Microbiol. 33:2957-2962.
32. zur Hausen, H. 1994. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr. Top. Microbiol. Immunol. 186:131-156.